Pfam Domains GO Terms
| TCR zetazeta |
| ITAM |
| IgE receptor activity |
| positive regulation of type III hypersensitivity |
| negative regulation of mast cell apoptotic process |
| positive regulation of type I hypersensitivity |
| regulation of type III hypersensitivity |
| regulation of mast cell apoptotic process |
| serotonin secretion |
| serotonin production involved in inflammatory response |
| Fc-epsilon receptor I complex |
| serotonin secretion by platelet |
| positive regulation of mast cell cytokine production |
| regulation of type I hypersensitivity |
| serotonin secretion involved in inflammatory response |
| positive regulation of type IIa hypersensitivity |
| positive regulation of type II hypersensitivity |
| regulation of type II hypersensitivity |
| regulation of type IIa hypersensitivity |
| IgE binding |
| interleukin-3-mediated signaling pathway |
| regulation of mast cell cytokine production |
| positive regulation of hypersensitivity |
| serotonin transport |
| regulation of hypersensitivity |
| positive regulation of acute inflammatory response to antigenic stimulus |
| interleukin-2 production |
| IgG binding |
| positive regulation of inflammatory response to antigenic stimulus |
| regulation of acute inflammatory response to antigenic stimulus |
| positive regulation of mast cell degranulation |
| positive regulation of mast cell activation involved in immune response |
| production of molecular mediator involved in inflammatory response |
| negative regulation of myeloid cell apoptotic process |
| positive regulation of protein localization to cell surface |
| cellular response to low-density lipoprotein particle stimulus |
| positive regulation of myeloid leukocyte cytokine production involved in immune response |
| positive regulation of mast cell activation |
| monoamine transport |
| mast cell activation |
| positive regulation of interleukin-4 production |
| positive regulation of leukocyte degranulation |
| regulation of inflammatory response to antigenic stimulus |
| response to lipoprotein particle |
| regulation of interleukin-4 production |
| positive regulation of acute inflammatory response |
| cellular response to lipoprotein particle stimulus |
| regulation of myeloid cell apoptotic process |
| regulation of platelet activation |
| positive regulation of myeloid leukocyte mediated immunity |
| T cell differentiation involved in immune response |
| regulation of mast cell degranulation |
| regulation of mast cell activation involved in immune response |
| positive regulation of interleukin-10 production |
| positive regulation of B cell mediated immunity |
| positive regulation of immunoglobulin mediated immune response |
| regulation of protein localization to cell surface |
| osteoclast differentiation |
| regulation of acute inflammatory response |
| regulation of mast cell activation |
| negative regulation of leukocyte apoptotic process |
| regulation of leukocyte degranulation |
| regulation of B cell mediated immunity |
| regulation of immunoglobulin mediated immune response |
| regulation of interleukin-10 production |
| ammonium transport |
| positive regulation of regulated secretory pathway |
| positive regulation of cytokine production involved in immune response |
| regulation of myeloid leukocyte mediated immunity |
| ficolin-1-rich granule membrane |
| receptor internalization |
| T cell activation involved in immune response |
| exocytic process |
| positive regulation of phagocytosis |
| tertiary granule membrane |
| antigen processing and presentation of exogenous peptide antigen via MHC class I |
| regulation of blood coagulation |
| regulation of hemostasis |
| regulation of coagulation |
| regulation of leukocyte apoptotic process |
| neutrophil chemotaxis |
| regulation of cytokine production involved in immune response |
| positive regulation of tumor necrosis factor production |
| positive regulation of tumor necrosis factor superfamily cytokine production |
| positive regulation of exocytosis |
| granulocyte chemotaxis |
| neutrophil migration |
| integrin-mediated signaling pathway |
| positive regulation of interleukin-6 production |
| regulation of phagocytosis |
| positive regulation of production of molecular mediator of immune response |
| antigen processing and presentation of peptide antigen via MHC class I |
| antigen processing and presentation of exogenous peptide antigen via MHC class II |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| antigen processing and presentation of peptide antigen via MHC class II |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| granulocyte migration |
| receptor metabolic process |
| positive regulation of adaptive immune response |
| positive regulation of lymphocyte mediated immunity |
| lymphocyte activation involved in immune response |
| myeloid leukocyte differentiation |
| stimulatory C-type lectin receptor signaling pathway |
| innate immune response activating cell surface receptor signaling pathway |
| myeloid leukocyte migration |
| platelet degranulation |
| phagocytosis, engulfment |
| positive regulation of leukocyte mediated immunity |
| T cell differentiation |
| Fc receptor mediated stimulatory signaling pathway |
| platelet activation |
| regulation of wound healing |
| plasma membrane invagination |
| organic hydroxy compound transport |
| positive regulation of inflammatory response |
| Fc-gamma receptor signaling pathway |
| regulation of interleukin-6 production |
| regulation of production of molecular mediator of immune response |
| leukocyte chemotaxis |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| membrane invagination |
| regulation of tumor necrosis factor production |
| regulation of lymphocyte mediated immunity |
| cytokine production |
| regulation of tumor necrosis factor superfamily cytokine production |
| regulation of adaptive immune response |
| regulation of regulated secretory pathway |
| regulation of response to wounding |
| Fc-epsilon receptor signaling pathway |
| antigen processing and presentation of exogenous peptide antigen |
| neurotransmitter transport |
| protein localization to plasma membrane |
| antigen processing and presentation of exogenous antigen |
| antigen processing and presentation of peptide antigen |
| regulation of leukocyte mediated immunity |
| immunoglobulin mediated immune response |
| positive regulation of intracellular transport |
| B cell mediated immunity |
| cell chemotaxis |
| antigen processing and presentation |
| positive regulation of immune effector process |
| myeloid cell differentiation |
| regulation of exocytosis |
| protein localization to cell periphery |
| innate immune response-activating signal transduction |
| T cell activation |
| lymphocyte differentiation |
| receptor-mediated endocytosis |
| Fc receptor signaling pathway |
| activation of innate immune response |
| lymphocyte mediated immunity |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| blood coagulation |
| coagulation |
| hemostasis |
| positive regulation of cellular protein localization |
| phagocytosis |
| defense response to bacterium |
| leukocyte differentiation |
| regulation of inflammatory response |
| protein homooligomerization |
| positive regulation of innate immune response |
| regulation of intracellular transport |
| positive regulation of response to biotic stimulus |
| leukocyte migration |
| lymphocyte activation |
| external side of plasma membrane |
| positive regulation of leukocyte activation |
| positive regulation of secretion by cell |
| positive regulation of cell activation |
| positive regulation of secretion |
| negative regulation of immune system process |
| positive regulation of cytokine production |
| immune response-activating cell surface receptor signaling pathway |
| regulation of innate immune response |
| regulation of immune effector process |
| positive regulation of defense response |
| wound healing |
| protein localization to membrane |
| immune response-regulating cell surface receptor signaling pathway |
| neutrophil degranulation |
| neutrophil activation involved in immune response |
| regulation of body fluid levels |
| inflammatory response |
| neutrophil mediated immunity |
| neutrophil activation |
| granulocyte activation |
| positive regulation of multi-organism process |
| leukocyte degranulation |
| myeloid leukocyte mediated immunity |
| protein complex oligomerization |
| regulation of response to biotic stimulus |
| myeloid cell activation involved in immune response |
| regulation of cellular protein localization |
| regulation of vesicle-mediated transport |
| chemotaxis |
| taxis |
| endocytosis |
| hemopoiesis |
| immune response-activating signal transduction |
| response to wounding |
| myeloid leukocyte activation |
| immune response-regulating signaling pathway |
| regulation of leukocyte activation |
| positive regulation of response to external stimulus |
| hematopoietic or lymphoid organ development |
| adaptive immune response |
| cell surface |
| leukocyte activation involved in immune response |
| cell activation involved in immune response |
| activation of immune response |
| regulation of cell activation |
| immune system development |
| cytokine-mediated signaling pathway |
| import into cell |
| response to bacterium |
| regulation of cytokine production |
| regulated exocytosis |
| regulation of secretion by cell |
| regulation of defense response |
| innate immune response |
| leukocyte mediated immunity |
| regulation of multi-organism process |
| exocytosis |
| regulation of secretion |
| cation transport |
| membrane organization |
| positive regulation of immune response |
| protein homodimerization activity |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| regulation of cellular localization |
| leukocyte activation |
| defense response to other organism |
| cell migration |
| positive regulation of transport |
| negative regulation of cell death |
| response to organonitrogen compound |
| secretion by cell |
| cellular response to cytokine stimulus |
| regulation of protein localization |
| export from cell |
| cell activation |
| cell motility |
| localization of cell |
| response to nitrogen compound |
| immune effector process |
| regulation of response to external stimulus |
| response to cytokine |
| secretion |
| regulation of immune response |
| positive regulation of immune system process |
| response to other organism |
| response to external biotic stimulus |
| locomotion |
| response to biotic stimulus |
| defense response |
| ion transport |
| integral component of plasma membrane |
| response to endogenous stimulus |
| regulation of response to stress |
| regulation of apoptotic process |
| movement of cell or subcellular component |
| protein-containing complex assembly |
| regulation of programmed cell death |
| cellular protein localization |
| cellular macromolecule localization |
| regulation of immune system process |
| regulation of cell death |
| positive regulation of multicellular organismal process |
| nitrogen compound transport |
| protein-containing complex subunit organization |
| regulation of transport |
| immune response |
| vesicle-mediated transport |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution